Literature DB >> 17536296

Social and personal consequences of acquired bowel dysfunction for persons with spinal cord injury.

M J Roach1, F S Frost, G Creasey.   

Abstract

BACKGROUND: Traditional literature regarding acquired bowel dysfunction for persons with spinal cord injury (SCI) has focused on clinical assessments of bowel dysfunction and bowel management programs. These studies make reference to the effects of bowel dysfunction on quality of life (QOL), but none systematically study the relationship. This study develops 4 scales that measure impediment to community integration (ICI) due to bowel dysfunction and then examines the relationship between bowel dysfunction, ICI, and QOL.
METHODS: A structured telephone survey was conducted with a convenience sample of 103 SCI consumers. Survey questions documented bowel dysfunction (ie, severity and number of accidents), bowel management (ie, how often bowels are evacuated), ICI, and satisfaction with 4 life domains.
RESULTS: Correlation analyses showed that subjective bowel dysfunction severity and number of days per month a respondent had to stay home because of lack of bowel control were associated with barriers to personal relationships, feelings about self, and home life. Also, the number of bowel accidents per month was associated with feelings about self. ICI scales were shown to be related to lower levels of satisfaction with free time, friendships, family life, and life in general. No statistically significant relationships were found between bowel dysfunction and satisfaction with life.
CONCLUSION: Bowel dysfunction is a barrier to community integration and is related to low levels of life satisfaction. Also, it is possible to quantify ICI related to bowel dysfunction. Educational programs can reduce the stigma associated with bowel dysfunction. Further research into the intricate relationships between bowel problems, barriers to participation in the community, and life satisfaction is needed.

Entities:  

Mesh:

Year:  2000        PMID: 17536296     DOI: 10.1080/10790268.2000.11753535

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  6 in total

1.  "It's just horrible": a qualitative study of patients' and carers' experiences of bowel dysfunction in multiple sclerosis.

Authors:  Lesley Dibley; Maureen Coggrave; Doreen McClurg; Sue Woodward; Christine Norton
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

2.  Provider adherence to implementation of clinical practice guidelines for neurogenic bowel in adults with spinal cord injury.

Authors:  Lance L Goetz; Audrey L Nelson; Marylou Guihan; Helen T Bosshart; Jeffrey J Harrow; Kevin D Gerhart; Barbara Krasnicka; Stephen P Burns
Journal:  J Spinal Cord Med       Date:  2005       Impact factor: 1.985

3.  Cost-Effectiveness Analysis of Transanal Irrigation for Managing Neurogenic Bowel Dysfunction in Japan.

Authors:  Atsushi Sengoku; Shinichi Noto; Masashi Nomi; Anton Emmanuel; Tatsunori Murata; Toshiki Mimura
Journal:  J Health Econ Outcomes Res       Date:  2018-02-12

4.  Neurogenic bowel treatments and continence outcomes in children and adults with myelomeningocele.

Authors:  Maryellen S Kelly; John S Wiener; Tiebin Liu; Priya Patel; Heidi Castillo; Jonathan Castillo; Brad E Dicianno; Joan Jasien; Paula Peterson; Jonathan C Routh; Kathleen Sawin; Eileen Sherburne; Kathryn Smith; Asma Taha; Gordon Worley
Journal:  J Pediatr Rehabil Med       Date:  2020

5.  Patient preferences for next generation neural prostheses to restore bladder function.

Authors:  P M H Sanders; M J Ijzerman; M J Roach; K J Gustafson
Journal:  Spinal Cord       Date:  2010-06-08       Impact factor: 2.772

Review 6.  Factors Which Facilitate or Impede Interpersonal Interactions and Relationships after Spinal Cord Injury: A Scoping Review with Suggestions for Rehabilitation.

Authors:  Delena Amsters; Sarita Schuurs; Kiley Pershouse; Bettina Power; Yvonne Harestad; Melissa Kendall; Pim Kuipers
Journal:  Rehabil Res Pract       Date:  2016-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.